Cite
HARVARD Citation
Kaňovský, P. et al. (n.d.). Sustained incobotulinumtoxinA (Xeomin) efficacy in upper limb poststroke spasticity over 48 weeks in A phase 3, placebo-controlled study with an open-label extension. Toxicon. pp. S47-S48. [Online].